Key Takeaways
- Record orders, muted revenue: Order intake hit a 10-quarter high of ₹515 crore, but revenue grew only 8% YoY as a large legacy order ended and Middle East conflict disrupted supply chains, right-shifting revenue into coming quarters.
- Margins inflected sustainably: EBITDA margin improved 125 bps on better mix, and management says new orders carry healthy margins, making the shift durable even as the revenue base rebuilds.
- Operating leverage is the margin engine: Capacity utilization sits at just 55-60% on two shifts; moving to three shifts can double revenue without adding factory lines, while indirect costs are already built for a $400M-$500M run rate.
- China Plus One tailwind building: U.S. OEMs are actively de-risking China dependence, driving a spike in RFQs from existing customers and new prospects; management expects positive impact in the next few quarters.
- What to watch next quarter: Whether the ₹515 crore order intake converts into revenue recovery, the pace of the defense segment rebuild after the large-order cycle ended, and any closure of the two BPS orders in finalization.
Order Book & Demand Visibility
- Record intake, broad-based: Q1 order intake of ₹515 crore was the highest in 10 quarters, drawn from all three industries and majorly from existing customers; Medical and Industrial orders came from new customers, a positive signal.
- Backlog quality improved: The ₹2,132 crore backlog now contains higher-margin orders, with nearly 50% executable in the current year; the mix is roughly 40% Aerospace & Defense, 9% Defense, and the balance split equally between Industrial and Medical.
- Book-to-bill confidence: Management is confident of sustaining a book-to-bill significantly above 1 for the full year, with next quarter already tracking above 1 based on current visibility and sales pipeline.
- Two BPS orders near closure: Two major build-to-spec orders are in finalization stage and expected to close in the current quarter, adding to the pipeline of multimillion-dollar B2S accounts.
- Order inflow consistency expected: Management sees no volatility in order intake going forward, citing current visibility and a strengthened sales pipeline; quarterly inflows should be more consistent.
Krishna Bodanapu: "It's worth highlighting that the backlog now contains higher-margin orders, signaling a favorable shift in our business compared to the previous periods, which will continue to be reflected in much better margins going forward."
Margin Trajectory & Operating Leverage
- 125 bps EBITDA improvement: Driven by better revenue mix, with new orders arriving at healthy margin numbers; management calls this a sustainable change, not a one-quarter event.
- Three margin levers identified: (1) operating leverage from low capacity utilization, (2) mix improvement as higher-margin new orders replace the legacy large order, (3) build-to-spec business scaling up, which gives better control over BOM, design services, and NRE work at higher margins.
- Capacity runway is substantial: Current utilization is 55-60% on two shifts; moving to three shifts can double revenue without adding factory or SMT lines, while indirect costs built for a $400M-$500M run rate will not grow linearly.
- Double-digit EBITDA commitment: Management is extremely confident of achieving double-digit EBITDA this year; the 9% Q1 print came on a lower revenue base, and as revenue picks up, significant leverage flows into the P&L.
- Gross margin assumption: The 40% contribution margin (material cost only) is a range that can be assumed going forward, though mix can shift quarter to quarter; management declined to give formal guidance.
Rajendra Velagapudi: "I think even with such a lower revenue in Q1, right, compared to what we have seen in, let's say, H2 of last year, we are already at 9%. So, imagine the next bit of the next INR 100 crores of revenue coming in at the same gross margin without any growth in the indirect costs. The leverage will play out very strongly in our favor."
Revenue Headwinds & Recovery
- Large legacy order ended: A very large order executed over the last two years has completely ended, creating a revenue hole that new orders, though higher-margin, have not yet filled; FY26 is described as a pivoting year where big revenue growth may not be seen.
- Middle East conflict right-shifted revenue: Iranian and Gulf airspace restrictions forced airlines to reroute, increasing flight times and costs; sea lane disruptions surged air freight demand, constraining space and driving up pricing; revenue was delayed, not lost, and will be recouped through the rest of the year.
- Defense segment degrew: Primarily due to the one large customer order completion, described as the cyclic nature of the business; the company is working with that customer for other opportunities and with other defense prospects in both the U.S. and India.
- Stand-alone business growing: Excluding the ended large order, the rest of the business is growing impressively; two accounts added last year have visibility to become multimillion-dollar accounts in the next one-year timeframe.
- Domestic market potential: The domestic market shows much higher potential than the export market; over the last 18 months, a solid foundation has been built, already showing results in current order intake.
Rajendra Velagapudi: "The domestic market shows a much higher potential than the export market. Our export market is more a legacy where we have strengths that we have played to in the past, which has led to higher growth. The domestic market has higher growth."
China Plus One & Geopolitical Tailwinds
- U.S. OEMs de-risking China: U.S. OEMs are actively reducing China dependence, and Cyient DLM's India-plus-U.S. hybrid model helps customers avoid tariff impact; a spike in RFQs is coming from existing customers and new U.S. prospects currently manufacturing in China.
- Hybrid production model in play: The company is working with customers on a model where low-cost offshore work happens in India with final assemblies at U.S. operations, reducing final product price; some work will move in both directions.
- Israel region RFQs rising: More RFQs are coming from the Israel region, with some expected to materialize this year.
- Demand acceleration expected: Across Aerospace & Defense, Medical, and Industrial sectors as the U.S. tariff situation stabilizes, China Plus One plays to advantage, and semiconductor/electronics use increases.
Build-to-Spec & Inorganic Strategy
- B2S scaling up: Build-to-spec revenue is about 5% of revenue in FY26; multimillion-dollar revenues are expected from B2S pipeline accounts in the near future, and the model gives better control over BOM, design services, and NRE work at higher margins.
- Altek integration progressing: The U.S. operations are now included in financials; the margin profile was similar to Cyient DLM's at acquisition, and as integration proceeds, synergy benefits flow into India books, making a split hard going forward.
- M&A strategy defined: Rather than filling gaps, future acquisitions will enhance existing capabilities (PCBA, box build, cable wire harness, design, build-to-spec); broad themes are customer proximity, regional capability, and technology focus.
- IPO M&A funds exhausted: Whatever was earmarked for M&A from IPO proceeds has been used; any new M&A would require a fund raise, though the company is in a healthy cash position with no pressure to raise.
- Factory digitalization near completion: The factory automation and digitalization initiative is expected to be completely closed by the end of this year.
Balance Sheet & Cash Flow
- Free cash flow positive: Third consecutive quarter of positive free cash flow, with almost ₹80-plus crore generated; net working capital metrics are healthy despite DIO appearing high, which is a denominator effect of lower revenue as absolute inventory has not grown much.
- IPO proceeds remaining: About ₹100 crore left, split between ₹60 crore for working capital and ₹40 crore for CAPEX; no pressure to raise funds.
- PAT impacted by non-cash items: Amortization of intangibles from M&A purchase price allocation and reduced other income as IPO funds are now largely deployed versus last year.
- Maintenance CAPEX only: The huge capacity runway means only maintenance CAPEX is needed; significant growth can be funded without major capital outlay.
G. V. Bodanapu: "The third element I will also highlight is we had a very good quarter from a cash flow perspective, having generated almost INR 80-plus crores of free cash. So, now this gives us the confidence that as growth comes back, and I say as growth comes fast, because Q1, there's just been a few one-off issues in terms of some of the new orders, some of the pushouts because of the Middle East."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Book-to-bill ratio | Significantly above 1 for the full year; next quarter already above 1 | FY26 full year; Q2 FY26 |
| EBITDA margin | Double-digit EBITDA; confident of exceeding 10% this year | FY26 |
| Revenue recovery (Middle East) | Right-shifted revenue recouped, not necessarily all in Q2 | Through rest of FY26 |
| Long-term revenue CAGR | 30% CAGR over 5 years, with odd years down and others higher | 5-year horizon |
| Capacity-driven growth | Revenue can double on existing capacity by moving to 3 shifts | No CAPEX needed |
| Factory digitalization | Initiative completely closed | By end of CY2025 |
| Two BPS orders | Closure expected | Current quarter (Q2 FY26) |
| Two new accounts | Expected to become multimillion-dollar accounts | Next 1-year timeframe |
| India Defense orders | Will see India Defense going up | Next few quarters |
| China Plus One impact | Positive impact expected from RFQ spike | Next few quarters |
Key Metrics
| Metric | Q1 FY26 |
|---|---|
| Revenue | ₹278.4 cr, +8% YoY; muted by large customer order completion and Middle East supply-chain disruption |
| EBITDA | ₹25.1 cr, +25.3% YoY |
| EBITDA margin | 9.0%, +125 bps YoY; improved revenue mix and better margin orders |
| PAT | ₹7.5 cr, margin of 2.7%; impacted by non-cash amortization of intangibles and lower other income |
| Contribution margin | ~40%, sharp improvement YoY and sequentially; sustainable range going forward |
| Order intake | ₹515 cr (~$60 mn), highest quarterly intake in the last 10 quarters |
| Book-to-bill ratio | ~1.9x, highest in the last 8 quarters |
| Order backlog | ₹2,132 cr, +₹225.7 cr QoQ; nearly 50% of new intake executable in FY26 |
| Order backlog mix | A&D ~40%, Defense 9%, Industrial and Medical balanced |
| Free cash flow | ₹80.2 cr, third consecutive quarter of positive cash generation |
| DIO | 185 days, elevated due to lower revenue denominator; absolute inventory stable |
| DPO | +15 days YoY improvement |
| Capacity utilization | 55–60% on a full-year basis, running 2 shifts; 3-shift operation could double revenue without new lines |
| B2S revenue expectation | ~5% of FY26 revenue |
| Standalone revenue | ~20% decline YoY, driven by completion of a large lumpy Defense order |